Alexander Herrmann

GILUPI GmbH develops and produces products for the in-vivo isolation of rare cells from the circulation. Its product GILUPI CellCollector enables the detection of rare cells directly from the blood of patients. The company was founded by Klaus Lücke, Ulrich Pison, Michael Giersig, and Fabian Rüchardt in 2006 and is headquartered in Potsdam, Germany.

Tas Transport Logistik GmbH is a logistics company based in Aschersleben, Germany. The German company provides a range of services including logistics, warehousing, pooling, and transport. Tas Transport Logistik GmbH was founded in 1997 and is led by CEOs Christoph Herrmann and Mandy Irmler.

Metabolomic Discoveries GmbH provides research and analytical services focusing on global metabolite profiling and fingerprinting. The firm uses technologies such as gas chromatography-mass spectrometry systems, Quadrupole time-of-flight mass spectrometers coupled to an ultra performance liquid chromatograph, Triple-Quadrupole mass spectrometer with ultrafast technology to analyze known and unknown metabolites in a sample. Its services include metabolite profiling, study of the lipidome, central metabolism quantification profiling, flavor profiling, measurement of non-organic or mineral elements in a biological sample, and flux analysis. The company was founded by Sandra Trenkamp and Nicolas Schauer in 2009 and is headquartered in Potsdam-Golm, Germany.

dentaZOOM GmbH develops and sells dental surgery microscopes. It provides a compact monocular surgery microscope called dentaZOOM, with 12-times magnification and an integrated LED light system. The microscope can be adjusted by its flexible shaft and allows best sight within the operational area as well as a fast control of treatment results. The company was founded in 2012 by Klaus-Peter Jurkat and is headquartered in Berlin, Germany.

Capsulution Pharma AG is a leading nanotechnology enterprise specialized in the customer-specific development of life-science products. As a spin-off of the Max Planck Society, its enterprise is a pioneer in the commercial utilization of the latest research results from the field of nanotechnology. They are opening up new frontiers by applying nanotechnology to the modern challenges of pharmaceutical therapy, medical technology and diagnostics. For this they use the years of expertise its staff and partners can offer as well as its internationally patented technologies for the production of multi-functional nanocapsules and nanocomplexes. Its nanocapsules and complexes are intelligent 'transport containers', so small that around 3 billion fit on the head of a single pin. Special processes allow them to furnish these tiny transport containers with a combination of pharmaceutical, biochemical, electrical, optical and magnetic properties. On this basis they are able to develop solutions that are always innovative and market-oriented, for example for more targeted and more effective drug delivery. Thanks to the right combination of specialized knowledge innovative spirit and reliability, Capsulution has been able to play the multiple roles of initiator, developer and consultant on the way to many a successful product.